Promega Corporation

Specific Detection of Biologically Active MAP Kinase using Anti-ACTIVE™ MAPK pAb

  • Share
  • Print
  • Email
  • Download PDF
  • Article
  • Comments & Ratings

Abstract

Promega's Anti-ACTIVE™ MAPK pAb, directed against the dually-phosphorylated form of the MAP kinase enzymes, allows for sensitive and specific detection of the active form of ERK1 and ERK2. This highly purified antibody is provided at high titer and can be used in a variety of immunodetection applications.

Promega Notes 58, 34.

Erik Schaefer and Rich Moravec

Promega Corporation
Publication Date: 1996

Download Article (193 KB)

  • Warning
  • It appears that you have Javascript disabled. Our website requires Javascript to function correctly. Please enable Javascript to experience our website.

Scientists at Your Service

We offer a range of services to help you succeed using Promega technologies. From product training to set up of automated systems and development of custom applications—our scientific support goes beyond the basics.

Ask us! We are here to help you.

Click Here for Technical Questions and Ordering Support »